Management is buying/committing capital at a price it says the market itself just set against it — cheapness measured ag
The model's full reasoning — Q3 2016 call → NOWe need to determine if management describes deliberately taking on more of its own economic exposure because it believes the outside world is mispricing what it already has. The key is: does management assert that the company's shares or assets are undervalued relative to something concrete, and is the company acting on that by buying back shares or otherwise concentrating exposure? In the transcript, management discusses share repurchases and dividends. For example, Bill Metzger says: "Since the beginning of our share repurchase program, in the fourth quarter of 2014, we have purchased approximately 4.8 million shares of stock. Over that time, shares outstanding have declined by approximately 3.5%." And later: "Our plan now assumes share repurchases of between $110 million and $120 million in 2016 and I would also like to point out we recently announced an increase in our quarterly dividend payments to $0.165 cents per share which is an increase from $0.15 per share." But is there any claim that the stock is undervalued? Management does not explicitly say the stock is cheap or that the market is mispricing the company. They talk about delivering on plans, but no concrete anchor like "our shares trade at a discount to book value" or "we believe our stock is undervalued." They mention that they are buying back shares, but they don't tie it to a mispricing claim. They also mention that they are increasing dividends, but that's routine. The question asks: "does management convey that outsiders (the market, buyers, lenders, appraisers, competitors, or counterparties) are presently valuing the company or its assets at a level management considers plainly too low relative to something concrete and verifiable, AND that the company is responding by ACQUIRING, RETAINING, OR CONCENTRATING that exposure right now rather than shedding it?" There is no such assertion. Management expresses confidence in the business, but no specific undervaluation claim. They talk about share repurchases as part of capital allocation, but not as a response to mispricing. They also mention that they are investing in growth, but that's not about buying back underpriced assets. Thus, the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CTHR | Charles & Colvard, Ltd. | Q1 2023 | 2022-11-06 | F |
| SBGI | Sinclair Broadcast Group, Inc. | Q3 2022 | 2022-11-02 | C |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
TWO · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the mispricing to concrete, verifiable levels: mortgage spreads at “historically wide” levels (125–150 bp ZV/OAS, far above the non-QE average and the March 31 levels), RMBS coupons now trading at a wide range (2 %–5.5 %) with 300 bp “out-of-the-money” low-coupon pools and 97 bp OAS–ZV spread differential on higher-coupon names.
ESEA · Q4 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete, verifiable figure: their own estimate of the fleet’s market value at $666 million (derived from charter-adjusted values and market changes, incorporating the Aegean Express incident), which produces a net asset value of $344 million or >$48 per share.
WD · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete benchmark: CoStar trades at ~30x EBITDA while W&D trades at under 10x despite identical revenue and EBITDA growth rates over 5–10 years. They explicitly state there is “plenty of multiple expansion available to W&D.